DOCSLIB.ORG

June 2021 Newsletter

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
June 2021 Newsletter NEWSLETTER June 2021 to advance education and research in the science of www.bap.org.uk psychopharmacology for the public benefit INSIDE 1 Message from the BAP President Message from the BAP President 2–3 Summer Meeting 2021 4–8 2021 I am delighted to report that Election for BAP Officers and Council our forthcoming 2021 Summer Members 8 Attitudes Towards Lithium Meeting, which will be held as a Project - Survey; 2021 Membership virtual event from Monday 19 to Subscriptions 9–10 The Unexpected Wednesday 21 July, contains all the usual exciting sessions. All the Benefits of Remote Working 10 VPM symposia planned for last year have been transferred Library 11 Media Activity 12 Education into the programme and will each include latest Events updates in their field. In addition to the usual Clinical and Non-Clinical sessions we have a special session discussing the impact of Covid-19 on mental health. All talks will be pre-recorded and available to members for a fixed period after the meeting. We are delighted to have received over 120 abstracts demonstrating the continued commitment to psychopharmacology British Association for research despite challenging times. I am particularly Psychopharmacology grateful that you have chosen the BAP as a forum to present this work. To maximise interaction between 36 Cambridge Place delegates, poster presenters will be asked to pre- Hills Road record a short oral explanation of their work which Cambridge CB2 1NS will become available the week prior to the meeting, with live question and answer during timetabled 01223 358 395 poster sessions. In addition to our usual poster prizes Executive Officer we have also introduced a ‘peoples prize’ voted for by Susan Chandler • [email protected] you, the delegates, for your favourite poster. I want to Assistant to the Executive Officer give special thanks to Sarah Channing-Wright (BAP) Lynne Harmer • [email protected] and Peter Tysoe (Stream Projects) who have built the Online Resources and Communications Developer BAP Live Online system so effectively to enable all Sarah Channing-Wright • [email protected] these sessions at our 2021 summer meeting to occur. Registration for BAP Training and student members For m @BAPsych is free, so please encourage the junior researchers in your group to take advantage of this opportunity. BritishAssociationforPsychopharmacology We may have to wait until 2022 for the disco and Gala Dinner to return, but I am confident that this /company/britishassociationforpsychopharmacology Summer Meeting will deliver the high-quality science that it is renowned for. The British Association for Psychopharmacology is registered in England as a Private Company No 5866899. Kevin Fone Registered Charity No 277825. HIGHLIGHTS 9 Invited Symposia 3 Post-Doctoral Symposia ⚫ Non-invasive neurostimulation treatments ⚫ The next phase of computational psychiatry: from first episode to treatment-resistant broader applications and novel methods depression: clinical efficacy and mechanisms ⚫ Heterogeneity in psychiatric illness: How far of action are we from personalised medicine? ⚫ Big data approaches to understanding mental ⚫ Predictive factors of adolescent mental health disorders and treatment response and translational implications of predictive ⚫ Chronic Fatigue Syndrome – Biological testing determinants and pathways to treatment Plenary Symposium, Monday 19 July ⚫ Mapping impulsivity and compulsivity: phenotypes, cognitive markers, neural domains Suicide: from basic to clinical science and treatment Suicide is an individual tragedy and a public health ⚫ Enabling translational psychopharmacology issue of major proportions. In this session leading through preclinical MR technology international experts will review the basic science of suicide in terms of neuroscientific and related ⚫ Does research on body-brain interactions processes; the clinical aspects with reference to hold promise for the development of novel the latest data driven approaches and the clinical treatments for addiction and eating disorders? psychopharmacology of antisuicidal treatments. ⚫ What can computational analyses of brain imaging data tell us about mechanisms in Trainees’ Workshop, Tuesday 20 July psychiatric disorders? Funding and Fellowships ⚫ Social neuropeptides: Central oxytocin and The BAP wants to support early career researchers vasopressin pathways and translational and trainees develop a career in psychopharmacology implications and translational research. This workshop will ⚫ Cognitive impairment in mood disorders - a consider the value of an early career fellowship/ forgotten pharmacological target? new investigator funding, a discussion of funding opportunities in this area, what makes for successful applications and networking opportunity with people who hold both non-clinical and clinical fellowships. 2 June 2021 Clinical Session, Wednesday 21 July translatability, or perhaps whether primate research, specifically in cortical regions, will be more fruitful. Are we getting closer to translatability in New techniques are allowing greater dissection of neuropsychiatric research? neuronal pathways and mechanisms involved in The panel will describe work based on the model of psychiatric disease and may yield more targetted experience dependent plasticity and brain dynamics approaches to therapy. Finally, one of the challenges in response to sensory stimuli and pharmacological across all areas of biomedical research has been challenge in the context of neurodevelopmental reproducibility. A number of industry-academic conditions such as autism (ASC). Dr Eva Loth will partnerships have been established to look at ways to describe the background and approach to the AIMS- improve the methodology and translational relevance 2-TRIALS project structures. Dr Judit Ciarrusta will of animal research - but are we getting any closer to describe her work on the biological underpinning of translatability? brain vulnerability to neurodevelopmental conditions in early infancy. Dr Nicolaas Puts will describe how Special Session, Wednesday 21 July neuroimaging methods (edited MRS of GABA) and COVID-19 Current Research transcranial magnetic stimulation can be used to examine the relationship between neurotransmitter SARS-CoV-2 infection, and the pandemic, are having concentration, GABA-receptor function, quantifiable substantial and diverse effects on mental and brain aspects of altered sensory perception, and health. This symposium will explore and discuss these clinical manifestations of ASC. Professor Grainne issues. Tom Nicholson will provide an overview of the McAlonan will provide an overview of current neuropsychiatry of COVID-19, and Max Taquet will clinical psychopharmacology in ASC as well as present electronic health records data on the incidence pharmacological responsivity in the adult ASC brain. and relative risks of psychiatric and neurological She will discuss how these approaches contribute disorders after COVID-19. Cognitive impairment and to work within AIMS-2-TRIALS (the world’s largest ‘brain fog’ are increasingly of concern in COVID-19 grant for ASC) to identify causal mechanisms in ASC survivors, and Adam Hampshire will show how and novel intervention targets. online cognitive assessments are shedding light on the severity and nature of these difficulties. Finally, Non-Clinical Session, Wednesday 21 July Cath Harmer will present novel data suggesting that statins influence resilience to depression during the Innovative medicine approaches for pandemic. The session will include plenty of time for neurodevelopmental disorders discussion. Translation of biomedical research into the clinic is a problem across all areas of research. For two decades the apparent failure of animal models For more information and to register, go to to deliver new treatments has been discussed. www.bap.org.uk/BAP2021 This symposium aims to address whether new developments in rodent models can deliver improved June 2021 3 2021 Election for BAP Officers Two Elected Council Member posts and Council Members (Post 1) Dr Sameer Jauhar has held this post as a casual vacancy for one year. The deadline for nominations for two Officer and two (Post 2) Dr Tom Freeman will retire from council. Council seats has now passed. Three nominations were received: Honorary General Secretary Sameer Jauhar Dr Peter Talbot will retire from Council. Steven Marwaha One nomination was received for the post of Honoary Digby Quested General Secretary, so Professor Rachel Upthegrove will be elected unopposed. Read Rachel’s statement Read all candidates’ statements below. below. Voting is online via the website only at www.bap.org.uk/vote and will close on MONDAY 28 Secretary for Non-Clinical External JUNE. The results will be announced at the electronic Affairs Annual General Meeting in July. Dr Sarah Bailey will retire from council. The BAP aims to represent the interests of all psychopharmacologists. Council asks Members to bear this One nomination was received for the post of Secretary in mind when voting, to ensure a balance of expertise. Please for Non-Clinical External Affairs, so Dr Maddy King refer to the BAP Equality, Diversity and Inclusion Statement will be elected unopposed. Read Maddy’s statement www.bap.org.uk/equality.php below. Current Officers and Council See website for biographies www.bap.org.uk/council ELECTED OFFICERS ELECTED COUNCIL MEMBERS Professor Kevin Fone Dr Sameer Jauhar President (Post 1) Dr Tom Freeman Professor David Baldwin (Post 2) President-Elect Professor Rachel Upthegrove
Load more

Recommended publications
  • Explanation of Conflict of Interest Disclosure Parts: Part One: All
    Explanation of Conflict of Interest Disclosure Parts: Part One: All Financial Involvement with a pharmaceutical or biotechnology company, a company providing clinical assessment, scientific, or medical companies doing business with or proposing to do business with ACNP over past 2 years (Jan. 2011-Present) Part Two: Income Sources & Equity of $10,000 or greater Part Three: Financial Involvement with a pharmaceutical or biotechnology company, a company providing clinical assessment, scientific, or medical products or companies doing business with or proposing to do business with ACNP which constitutes more than 5% of personal income (Jan. 2011-Present): Part Four: Grants from pharmaceutical or biotechnology company, a company providing clinical assessment, scientific, or medical products directly, or indirectly through a foundation, university, or any other organization (Jan. 2011-Present) Part Five: My primary employer is a pharmaceutical/biotech/medical device company. 2012 Program Committee Disclosures Anissa Abi-Dargham: Part 1: Pfizer; Otsuka; Takeda; Sunovion; Shire; Roche; Pierre Favre; Part 2: Pierre Favre William Carlezon: Part 1: Referring to 2010-2011: Scientific Advisory Board, Myneurolab.com; Consultant, Concert Pharmaceuticals; Consultant, Lantheus Medical Imaging; Consultant, Transcept Pharmaceuticals, (Spouse) Senior Scientist, EMD Serono; Part 2: (Spouse) Senior Scientist, EMD Serono, Part 3: (Spouse) Senior Scientist, EMD Serono Cameron Carter: Part1: GlaxoSmithKline research; Part 4: GlaxoSmithKline Karl Deisseroth: Part
    [Show full text]
  • IMH Colloquium Serie
    Interdisciplinary Colloquium Series for 2008 - 2009 Sponsored by the UBC INSTITUTE OF MENTAL HEALTH Sept. 10 Barbara Sahakian: Cognition in Depression and Mania WED. Professor of Clinical Neuropsychology, Dept. of Psychiatry and MR/Wellcome Trust Behavioural and Clinical Neuroscience Institute, University of Cambridge Co-sponsored by National Core for Neuroethics. 2nd talk on TH., Sept. 11, as part of its inaugural ceremonies. Oct. 2 Marten deVries: Minds, Media, & Early Education: Public Mental Health & Media Approaches for Children Under Difficult Conditions & Disaster Professor of Social Psychiatry and Head of Center for Public Mental Health, Maastricht University; Founder, International Inst. Psycho-social and Socio-ecological Research (IPSER) Co-sponsored by Div. of Child & Adolescent Psychiatry. 2nd talk Fri., Oct. 3, noon, at Children’s Hospital: the Dr. Hira Panikkar Memorial Lecture: Babies, Brains & Culture: Health & Development in the Context of Cultural Diversity; Cases from East Africa Nov. 6 Joseph Trimble: Infusing Psychology Courses with Diversity Content: Truths, Half-Truths, and Anecdotes in Cross-Cultural Psychology Professor, Center for Cross-Cultural Research, Dept. of Psychology; Director, Office of Institutional Assessment, Research, and Testing, Western Washington University Co-sponsored by the National Core for Neuroethics. 2nd talk Fri., Nov. 7, noon, Neuroethics Conference Room (Koerner S117): Responsible and Ethical Conduct of Research with Ethnocultural Populations Dec. 11 Steven Marans: Childhood Trauma: Challenges to Listening and Responding Harris Prof. of Child Psychiatry & Prof. of Psychiatry, Child Study Center, Yale University School of Medicine and Director, National Center for Children Exposed to Violence Co-sponsored by Div. of Child & Adolescent Psychiatry. 2nd talk Fri., Dec. 11, noon, at Children’s Hospital: Hands on Problem-Solving in Listening and Responding to Traumatized Children Feb.
    [Show full text]
  • Year in Review 2018
    Year in Review 2018 International Neuroethics Society Message from the President I was honored to become President of the International Neuroethics Society in November 2017 and to have a chance to build on the excellent work of my predecessors, Judy Illes, Barbara Sahakian, and Steve Hyman. I set out three goals for my two years as President: • To increase opportunities in the Society for INS members • To boost the public role of the INS in discussions, scholarly and public, of neuroethics and • To increase INS membership. I am pleased to report that we have increased the opportunities for members to take part in the Society’s activities with new committees and task forces. We have reached out to the public through, for example, our public event at the Annual Meeting on ‘My Brain Made Me Buy It? The Neuroethics of Advertising’ and our essay competition in which our members were invited to write for the lay reader. Building our membership, however, has been a little more challenging. Neuroethics is in some ways a niche field but with advances in brain research raising ever more social and ethical dilemmas, it is vital that scientists, philosophers and clinicians become involved. I am eager to get more regional INS meetings, giving opportunities for members to get together apart from the one annual meeting and to spread the word about neuroethics. We have made good progress here in 2018 with events in Oxford, UK; Milwaukee, USA; and Sydney, Australia. We have been developing new partnerships with other like-minded organizations and participating in conferences around the world.
    [Show full text]
  • Networks of Expertise and Evidence for Public Policy Annual Report 2015 the Centre for Science and Policy in 2015
    Networks of Expertise and Evidence for Public Policy Annual Report 2015 The Centre for Science and Policy in 2015 The policy challenges facing our world today demand ever-greater foresight, ingenuity and a willingness to collaborate across sectors. As this report illustrates, “Over the seven years since its launch, the Centre for Science the Centre for Science and Policy has been helping its network to navigate and Policy has pioneered new ways of bringing academia and challenges from climate resilience to new forms of healthcare; from national government together to tackle policy challenges. CSaP has security to shaping innovation in the public interest. successfully promoted long-term thinking and more robust networks of expertise and evidence for public policy. The maturity of CSaP’s unique network of academics As he moves on to chair CSaP’s Advisory Council, I and policy makers is demonstrated by the breadth would like to express my gratitude to David for his Dr Robert Doubleday and depth of our work during 2015. Our network inspirational work in founding the Centre. Executive Director Centre for Science and Policy 2015 is the year in which the Centre came of age. Having now encompasses over 200 Fellows and more than served as its founding director from 2009 to 2015, I am 1100 researchers and, during the year, we welcomed In 2016, a year set to be every bit as challenging for delighted CSaP is playing a central role in supporting the more than 2500 participants to 43 events. governments as 2015 has been, CSaP’s role in brokering links between research and policy will be University’s mission, and that the Centre is in the excellent These achievements are testimony to the vision of more important than ever.
    [Show full text]
  • Panel and Study Groups
    Neuropsychopharmacology (2012) 38, S1–S78 & 2012 American College of Neuropsychopharmacology All rights reserved 0893-133X/12 www.neuropsychopharmacology.org S1 Monday, December 03, 2012 Conclusions: The signaling differences identified in this study have important implications in screening different KOR agonists and antago- nists having distinctly different ligand directed signaling properties. Mini Panel Disclosure: C. Chavkin, Part 1: Consulting for Trevena 2010-2011, 1. Renaissance in Opioid Biology: From Preclinical Concepts to Part 2: Contract with Trevena 2010-2011. Clinical Practice 1.2 The Place of Opiates in the Cortico-basal Ganglia Reward 1.1 Molecular Basis for Kappa Opioid Receptor Antagonism: Circuit Implications of Ligand-directed Signaling for the Development of Novel Antidepressants Suzanne Haber* Charles Chavkin* University of Rochester, Rochester, New York University of Washington, Seattle, Washington Background: Reward is a central component for driving incentive- based learning, appropriate responses to stimuli, and habit Background: Preclinical studies have demonstrated the role of formation. Pathology in this circuit is associated with several stress-induced dynorphin release in mediating a component of the diseases including addition. The ventral medial prefrontal cortex anxiogenic and aversive effects of stress exposure. These results (vmPFC), orbital prefrontal cortex (OFC), dorsal anterior cingulate suggest that kappa opioid receptor (KOR) antagonists or low cortex (dACC), striatum, ventral pallidum, and midbrain dopamine efficacy partial agonists may promote stress-resilience in humans neurons are at the center of the circuit associated with reward in and may potentially be useful in treating certain forms of mood general and, in particular addiction. Connectivity between these disorders exacerbated by stressful experience. In rodent models, areas forms a complex neural network that mediates different stress-induced stimulation of dynorphin release produces aversion, aspects of reward processing, that can lead to habit formation.
    [Show full text]
  • June 2012 Newsletter
    Newsletter “To advance education and research in the science of psychopharmacology for the public benefit” June 2012 2012 SUMMER MEETING, SUNDAY 22 TO WEDNESDAY 25 JULY, HARROGATE INTERNATIONAL CENTRE Full details of sessions are on the website, together with registration facilities http://bap.org.uk/summermeetinghome.php?meetingID=5 Highlights: The 2012 Guest Lecture, presented by Dr Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) Plenary Mental Health Session, “The best treatment for treatment-resistant patients with psychiatric disorders and possibilities for developing clinical research”, including presentations from Stephen Stahl, Guy Goodwin, Gavin Malloch and Kathryn Adcock 9 invited symposia covering cutting-edge clinical and non-clinical psychopharmacology: Drugs as tools in neuropsychiatry: Ketamine; New tricks for old drugs: Opiates, addiction and beyond; Advances in understanding brain corticosteroid responses to stress: relevance to depression; Cognitive impairment in depression: A target for treatment?; New treatment strategies for targeting drug addictions – A translational perspective; Functional imaging markers for monitoring treatment: Mechanisms and efficacy; Schizophrenia Treatment: What’s wrong with it and what might work better; Epigenetics and psychiatry - current understanding and therapeutic potential; Rethinking the compulsive aspects of addiction: From bench to bedside 2 dedicated Poster Sessions Post-doc Symposium, “Neurodevelopmental models of psychiatric disease: back to the future” Satellite
    [Show full text]
  • International Neuroethics Society
    Neuroethics Society www.neuroethicssociety.org — September, 2009 Call for Papers Foretell an Extended Neuroethics Literature Martha J. Farah, N.S. Newsletter Editor Over the summer we received two "Calls neuroethics, neuroaesthetics, the neuro- purview of neuroethics? What roles do for Papers," or CFPs, as they are known humanities, and neurohistory to name but print and digital media play in the devel- in the humanities world. We reprint a few. We are seeking essays for an ed- opment and distribution of this trend? them in their entirety here, because we ited collection that analyze and interro- Why and how do the humanities and the think they will be of interest to NS mem- gate this recent neuroscientific turn in the social sciences need the neurosciences? bers and because they make interesting humanities and social sciences. We are What can the neurosciences learn from reading in their own rights! particularly interested to hear from re- this trend in the humanities and the social searchers who apply the neuro- to their sciences? How might these fields combine NS members come mostly from back- own disciplinary work. into a discipline of their own? grounds in the natural and social sciences, Essays might engage with the following Related fields include: but if these CFPs are an indication, schol- questions: why has there been a shift to Neuroaesthetics ars in the humanities are also developing using neuroscience as an epistemological Social Neuroscience (neuro- an interest in neuroscience and its influ- framework and/or theoretical
    [Show full text]
  • Neuroethics Event Calendar Members Are Encouraged to Submit Event Listings for Consideration to [email protected]
    Neuroethics Society www.neuroethicssociety.org — Volume 2, Number 3 May, 2008 Writing Prize in Neuroethics: Winners Announced Megan Kaufman, NS Assistant Administrator The Neuroethics Society is nal’s sixth bi-annual issue is centered Geneva University Medical School, proud to announce the winners of the around neuroethics with the NS publiciz- Heather Knapp of the University of Neuroethics Prize in Writing, jointly ing the call for papers and helping to se- Washington, Mike Kuhar of Emory Uni- sponsored by the Society and the edito- lect winners for the writing contest. Bo rial board of the Penn Bioethics Journal Peng described the nature of the collabo- Continued on page 2 (PBJ). Awards went to the top three ration: “We often have themed issues for neuroethics-themed articles submitted by the journal such as public health, organ undergraduates to PBJ, the nation’s pre- transplantation, and international bio- miere undergraduate bioethics journal, ethics, so with the growing nature of neu- published and edited by students at the roethics, it was very appropriate to cre- University of Pennsylvania. The editorial ate this issue. We received a number of board at the Journal initially reviewed all neuroethics and other bioethics papers the submitted articles and nominated from undergrads at ten different schools three outstanding pieces for review by a and ran them through our normal review committee of Neuroethics Society mem- process with the editorial board. We bers. The committee selected the winner were left with 3 papers to be judged for and two runners up, each receiving a the writing prizes.” prize for their work.
    [Show full text]
  • The Young Univ Gallery the Martlet | Winter 2016
    THE YOUNG UNIV GALLERY WINTER 2016 | THE MARTLET Over the past months, the College has created a photographic record of almost 50 Old Members aged 35 or under called The Young Univ Gallery. The gallery highlights many of the important, unusual and impressive journeys taken by our young alumni. All of the portraits will be on display in College from March 2017. The project aims to inspire current and prospective students by showing the wide range of paths open to them on leaving College. All of the portraits will also be on display on a dedicated website, along with extensive biographies, interviews and a short fi lm about the project. We hope everyone will be inspired by The Young Univ Gallery. UNIVERSITY COLLEGE OXFORD ISSUE 6 SPRING 2017 THE YOUNG UNIV GALLERY CELEBRATING INSPIRATIONAL OLD MEMBERS UNDER 35 ALSO IN THIS ISSUE VETERAN JOURNALIST AND BROADCASTER RAJDEEP SARDESAI (1986) ISSUE 6 THE ASSASSIN IN THE COMPUTING ROOM: PRINCE YUSUPOV AND THE ‘MAD MONK’ SHOOTING THE PAST WITH ALEX VON TUNZELMANN (1996) FROM THE EDITOR University College Oxford OX1 4BH elcome to the Spring 2017 issue of The Martlet, the magazine for www.univ.ox.ac.uk members of University College Oxford. I would like to express my sincere thanks to those Old Members, students, Fellows, staff and www.facebook.com/universitycollegeoxford WFriends of the College who contributed to this issue. www.twitter.com/univoxford Enormous thanks also to Dr David Bell, Emeritus Fellow, and Justin Bowyer, Social Registered Charity no. 1141259 Media Manager, who provided copy-editing support for this issue.
    [Show full text]
  • Behavioral Finance: Investors, Corporations, and Markets
    $95.00 USA/$114.00 CAN (continued from front flap) KOLB SERIES IN FINANCE Behavioral Finance contains the latest information Essential Perspectives Nofsinger Baker from some of the leading practitioners and academics in this fi eld. Engaging and accessible, this book provides a clear understanding of how people make fi nancial BEHAVIORAL decisions and their effects on today’s markets. BEHAVIORAL FINANCE ehavioral fi nance has increasingly become part of mainstream fi nance—helping to H. KENT BAKER, PH D, CFA, CMA, is The Robert W. Kolb Series in Finance is an unparalleled source of informa- provide explanations for our economic University Professor of Finance and Kogod B FINANCE decisions by combining behavioral and cognitive tion dedicated to the most important issues in modern fi nance. Each book Research Professor at the Kogod School of focuses on a specifi c topic in the fi eld of fi nance and contains contributed psychological theory with conventional economics Business, American University. He has published chapters from both respected academics and experienced fi nancial profes- Investors, Corporations, and fi nance. extensively in leading academic and professional sionals. As part of the Robert W. Kolb Series in Finance, Behavioral Finance fi nance journals including the Journal of Finance, Filled with in-depth insights and practical advice, aims to provide a comprehensive understanding of the key themes associated and Markets Journal of Financial and Quantitative Analysis, this reliable resource—part of the Robert W. Kolb with this growing fi eld and how they can be applied to investments, corpora- FINANCE BEHAVIORAL Financial Management, Financial Analysts Journal, Series in Finance—provides a comprehensive view tions, markets, regulations, and education.
    [Show full text]
  • “CHILDREN” by Amelia Buttress a Dissertation
    THE CHEMICAL LIVES OF “CHILDREN” by Amelia Buttress A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland August 2014 ABSTRACT Stimulants and ADHD have become nearly synonymous in recent decades. The now common practice of prescribing stimulants to children has fueled the long-standing controversy surrounding the legitimacy of what is commonly known as Attention Deficit Hyperactivity Disorder (ADHD). The need to medically justify stimulant use has sharpened the debate between those who argue for the disorder’s medical validity and those who describe the disorder as a social construction. Historical inquiry into ADHD has maintained this dichotomy, retroactively fusing psycho-stimulants and children, and reifiing rather than challenging a false choice between medical and constructivist explanations of the disorder. This dissertation reexamines the significance of psychostimulants to two doctors in their work with children. Charles Bradley and Leon Eisenberg have, in recent years, figured prominently in historical accounts of ADHD as pioneering advocates of psychopharmalogical treatment of children with hyperactive and inattentive children, in particular with stimulants. Scholars have selectively mined the published works of these two doctors to either validate or contest a biomedical explanation of ADHD and, thus, the appropriateness of pharmacologic treatment. However, each man wrote during distict periods in American intellectual history, and their interpretation of the issues of the day influenced how they framed the results of their studies. A careful reading of the published works of Bradley and Eisenberg in light of their broader historical, intellectual and therapeutic contexts illuminates how both men derived a much wider range of uses for and i interpretations of stimulants as a diagnostic and therapeutic tool for a range of children’s disorders.
    [Show full text]
  • Mental Capital and Wellbeing Final Project Report
    Mental Capital and Wellbeing: Mental Capital and Wellbeing: Making the most of ourselves in the 21st century Making the most of ourselves in 21st FINAL PROJECT REPORT FINAL PROJECT Mental Capital and Wellbeing: Making the most of ourselves in the 21st century Printed in the UK on recycled paper with a minimum HMSO score of 75 First published October 2008. The Government Office for Science. © Crown copyright. URN 113-08-Fo/b. FINAL PROJECT REPORT 7700-DIUS-Mental Capital and Wellbeing COV A/W.indd 1 10/10/08 13:48:27 Mental Capital and Wellbeing: Making the most of ourselves in the 21st century This report is intended for: Policy makers and a wide range of professionals and researchers whose interests relate to mental capital and wellbeing. The report focuses on the UK but is also relevant to the interests of other countries. This report should be cited as: Foresight Mental Capital and Wellbeing Project (2008). Final Project report. The Government Office for Science, London. 7700-DIUS-Final Project Report5.indd 2 10/10/08 14:17:38 The Government Office for Science (GO-Science) would like to thank the Project’s Science Co-ordination Team who oversaw the technical aspects of the Project, who were involved in much of the work, and who were particularly involved in writing this final report. They were led by Professor Cary Cooper, CBE and are Professor John Field, Professor Usha Goswami, Professor Rachel Jenkins and Professor Barbara Sahakian. GO-Science would also like to thank: Professor Philip Dewe, Professor Eugene Paykel, Professor Felicia Huppert and Mr Chris Riley who also contributed to this final report; Professor Leon Feinstein, Professor Tom Kirkwood and Professor Michiel Kompier who led parts of the first phase of the Project; and the company shiftN who worked on the futures and systems aspects.
    [Show full text]